Donner et al., 1961 - Google Patents

The hemostatic defect of acute and chronic uremia

Donner et al., 1961

Document ID: 8281604260788650183
Author: Donner L; Neuwirtova R
Publication year: 1961
Publication venue: Thrombosis and Haemostasis

External Links

Cited by

Snippet

1. Investigations of blood coagulation in 52 acute, and 38 chronically uremic patients were performed. Clinical bleeding tendency were noted in 16 (30, 8%) patients with acute uremia and in 13 (34, 2%) with chronic uremia. In 237 extracorporeal dialysis carried out during the …

Continue reading at www.thieme-connect.com (other versions)

206010003885 Azotaemia 0 title abstract description 88

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication	Publication Date	Title
Kanfer et al.	1970	Coagulation studies in 45 cases of nephrotic syndrome without uremia
Ratnoff et al.	1955	A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma
Green Jr et al.	1978	Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage
Rand et al.	1969	Coagulation defects in acute promyelocytic leukemia
CASTRO et al.	1972	Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus
Brain et al.	1968	Treatment of patients with microangiopathic haemolytic anaemia with heparin
Stefanini	1953	Mechanism of blood coagulation in normal and pathologic conditions
Girolami et al.	1971	Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family
Kwaan	1972	Disseminated intravascular coagulation
Donner et al.	1961	The hemostatic defect of acute and chronic uremia
Rapaport et al.	1967	The blood clotting properties of rabbit peritoneal leukocytes in vitro
Stefanini	1954	Basic mechanisms of hemostasis
Jacox	1949	Studies on the activation of a serum “prothrombin-converting factor”
EP0303236B1 (en)	1992-11-11	Lignosulfonate based pharmacologic agent with anti-thrombotic activity
Johnson et al.	1958	A new approach to the thrombocytopathies. Thrombocytopathy A
Howell	1939	Hemophilia: The Wesley M. Carpenter Lecture
RAMOT et al.	1955	Plasma Thromboplastin Antecedent: Deficiency
Handley et al.	1969	A circulating anticoagulant specific for factor V
Brown III et al.	1975	Glanzmann's thrombasthenia; assessment of the response to platelet transfusions
Thom et al.	1978	The effect of different regimens of oestrogens on the clotting and fibrinolytic system of the post-menopausal woman
Kalant et al.	1952	Treatment of paroxysmal nocturnal hemoglobinuria with ACTH
Girolami et al.	1973	Abnormal Factor X (Factor X Friuli) Coagulation Disorder: First Report of a Case Outside Friuli
Cosgriff et al.	1952	Factor 5 deficiency in hemorrhagic diathesis (parahemophilia)
Ratnoff et al.	1960	Physiologic and pathologic effects of increased fibrinolytic activity in man: With notes on the effects of exercise and certain inhibitors on fibrinolysis
Poller	1960	The possible relationship between the anti-heparin activity of serum and thrombosis